NVNO: הכנסות ממכירות החברה enVVeno Medical Corp.

The resilience of enVVeno Medical (NVNO) is based on the strong pricing power of the unique VenoValve bioprosthesis. The company's sales performance confirms this trend, where the value of 0.00 expresses the metric level. Revenue is generated through insurance reimbursements to clinics for vascular surgeries. Currently, the business is deploying its existing capital toward costly clinical trials pending final regulatory approval.
פילוחי מדדים מקיפים ואנליטיקה עבור enVVeno Corp (NVNO)

This indicator tracks daily cash inflows from core product sales, determining the operational resilience of the business. The dynamics of this flow directly impact the calculated asset value, revealing the gap between market expectations and actual revenue. By analyzing the company's aggregate sales levels, an investor can assess the risk of capital overvaluation. For enVVeno Medical (NVNO), this metric will serve as key confirmation of the successful commercial launch of the VEST valve.